183 related articles for article (PubMed ID: 31443715)
1. Pure secretory carcinoma in situ: a case report and literature review.
Yang Y; Wang Z; Pan G; Li S; Wu Y; Liu L
Diagn Pathol; 2019 Aug; 14(1):95. PubMed ID: 31443715
[TBL] [Abstract][Full Text] [Related]
2. Secretory breast carcinoma with a papillary-predominant pattern: an unusual morphological variant.
Shui R; Cheng Y; Bai Q; Yang W
Histopathology; 2017 Sep; 71(3):488-493. PubMed ID: 28383794
[TBL] [Abstract][Full Text] [Related]
3. Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum.
Laé M; Fréneaux P; Sastre-Garau X; Chouchane O; Sigal-Zafrani B; Vincent-Salomon A
Mod Pathol; 2009 Feb; 22(2):291-8. PubMed ID: 19011601
[TBL] [Abstract][Full Text] [Related]
4. Cystic hypersecretory (in situ) carcinoma of the breast: a clinicopathologic and immunohistochemical characterization of 10 cases with clinical follow-up.
D'Alfonso TM; Ginter PS; Liu YF; Shin SJ
Am J Surg Pathol; 2014 Jan; 38(1):45-53. PubMed ID: 24121179
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathologic features of secretory breast carcinoma].
Zhang F; Shi M; Liao Q; Zhou CM
Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):628-632. PubMed ID: 31434456
[No Abstract] [Full Text] [Related]
6. [Clinicopathologic features of cystic hypersecretory lesion of the breast].
Bi R; Cheng Y; Yu B; Shui R; Yang W; Xu X
Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):25-9. PubMed ID: 24713245
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathologic study of intracystic papillary carcinoma of the breast].
Yang WT; Yu L; Lu HF; Zhang TQ
Zhonghua Bing Li Xue Za Zhi; 2008 Apr; 37(4):234-7. PubMed ID: 18844031
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathologic study of infiltrating epitheliosis of the breast].
Xu XL; Tu XY; Shui RH; Cheng YF; Yu BH; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2017 Dec; 46(12):827-831. PubMed ID: 29224275
[No Abstract] [Full Text] [Related]
9. Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers.
Collins LC; Carlo VP; Hwang H; Barry TS; Gown AM; Schnitt SJ
Am J Surg Pathol; 2006 Aug; 30(8):1002-7. PubMed ID: 16861972
[TBL] [Abstract][Full Text] [Related]
10. Secretory Breast Carcinoma: A Histopathologic and Genomic Spectrum Characterized by a Joint Specific ETV6-NTRK3 Gene Fusion.
Del Castillo M; Chibon F; Arnould L; Croce S; Ribeiro A; Perot G; Hostein I; Geha S; Bozon C; Garnier A; Lae M; Vincent-Salomon A; MacGrogan G
Am J Surg Pathol; 2015 Nov; 39(11):1458-67. PubMed ID: 26291510
[TBL] [Abstract][Full Text] [Related]
11. Mammary analogue secretory carcinoma of salivary glands: a clinicopathologic study of 11 cases.
Din NU; Fatima S; Kayani N
Ann Diagn Pathol; 2016 Jun; 22():49-53. PubMed ID: 27180060
[TBL] [Abstract][Full Text] [Related]
12. Molecular Profiling of Salivary Gland Intraductal Carcinoma Revealed a Subset of Tumors Harboring NCOA4-RET and Novel TRIM27-RET Fusions: A Report of 17 cases.
Skálová A; Vanecek T; Uro-Coste E; Bishop JA; Weinreb I; Thompson LDR; de Sanctis S; Schiavo-Lena M; Laco J; Badoual C; Santana Conceiçao T; Ptáková N; Baněčkova M; Miesbauerová M; Michal M
Am J Surg Pathol; 2018 Nov; 42(11):1445-1455. PubMed ID: 30045065
[TBL] [Abstract][Full Text] [Related]
13. Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers.
Urano M; Nagao T; Miyabe S; Ishibashi K; Higuchi K; Kuroda M
Hum Pathol; 2015 Jan; 46(1):94-103. PubMed ID: 25456394
[TBL] [Abstract][Full Text] [Related]
14. Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics.
Tsang WY; Chan JK
Am J Surg Pathol; 1996 Aug; 20(8):921-43. PubMed ID: 8712293
[TBL] [Abstract][Full Text] [Related]
15. [Invasive carcinoma arising in breast microglandular adenosis: a clinicopathologic study of three cases and review of the literature].
Shui RH; Cheng YF; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2011 Jul; 40(7):471-4. PubMed ID: 22088374
[TBL] [Abstract][Full Text] [Related]
16. Dedifferentiated secretory breast carcinoma with fibrosarcomatous features harboring an ETV6-NTRK3 fusion in both components.
Xu J; Weisman P
Genes Chromosomes Cancer; 2021 Jun; 60(6):447-451. PubMed ID: 33342011
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain.
Werling RW; Hwang H; Yaziji H; Gown AM
Am J Surg Pathol; 2003 Jan; 27(1):82-90. PubMed ID: 12502930
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological features and genomic profiles of a group of secretory breast carcinomas in which progressive cases have more complex genomic features.
Lei T; Yang Y; Shi Y; Deng X; Peng Y; Wang H; Chen T
Diagn Pathol; 2022 Dec; 17(1):101. PubMed ID: 36585729
[TBL] [Abstract][Full Text] [Related]
19. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
Latta EK; Tjan S; Parkes RK; O'Malley FP
Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
[TBL] [Abstract][Full Text] [Related]
20. Secretory Carcinoma of the Skin Harboring ETV6 Gene Fusions: A Cutaneous Analogue to Secretory Carcinomas of the Breast and Salivary Glands.
Bishop JA; Taube JM; Su A; Binder SW; Kazakov DV; Michal M; Westra WH
Am J Surg Pathol; 2017 Jan; 41(1):62-66. PubMed ID: 27631515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]